Wednesday, 1 June 2016

Phase 1 trial results for tumor resection + Toca511 and TocaFC

Study results were just published today in Science Translational Medicine.  Find the study in the main area of the Library.
Posted by at
Labels:

2 comments:

  1. Matjaz23 February 2017 at 06:35

    Tocagen Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Toca 511 & Toca FC in Recurrent High Grade Glioma

    http://finance.yahoo.com/news/tocagen-receives-breakthrough-therapy-designation-130000791.html

    ReplyDelete
    Replies
    1. Unknown23 February 2017 at 13:48

      More good news in the brain cancer research world. Progress continues forward.

      Delete

Subscribe to: Post Comments (Atom)